Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Industriels
  2. Médicament
  3. SOLUMEDROL (hémisuccinate de méthylprednisolone)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
  • Date 01 July 2015
  • Documents : 1
  • History
Listen Listen
Add to my selection
  • Maintien du remboursement dans les mêmes conditions
  • Clinical Benefit
Quote this publication
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

SOLUMEDROL (hémisuccinate de méthylprednisolone)

Opinions on drugs - Posted on Jul 17 2015

Reason for request

Renouvellement d'inscription

Maintien du remboursement dans les mêmes conditions


Clinical Benefit

Substantial

Le service médical rendu par les spécialités SOLUMEDROL reste important dans les indications de l’AMM.


Documents

  • SOLUMEDROL_01072015_AVIS_CT13586 Xvox

Contact Us

Évaluation des médicaments
  • Contact Us
All our publications
    Allergy Autoimmune diseases Blood and lymphatic diseases - miscellaneous Central nervous system diseases Demyelinating diseases Drug therapy Infectious diseases - miscellaneous Joint and rheumatic diseases Kidney diseases Laryngeal diseases Paediatrics Pain - Inflammation Skin and connective tissue diseases Transfusions, transplantations Vascular diseases - miscellaneous

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
gqKr9xRtLfW7RD3m